IIT Bombay welcomes the first batch of scholars to the Medical Technology Research and Innovation Centre (MED-TRIC)!
Under the leadership of Professor-in-Charge Prof. Rohit Srivastava, MED-TRIC marks the beginning of a first-of-its-kind interdisciplinary Ph.D. programme in Medical Innovations. The Centre brings together clinicians, engineers, scientists and industry experts to develop indigenous healthcare technologies that address real clinical challenges through research, innovation and translational impact. We wish our inaugural cohort a successful journey as they shape the future of medical technology and healthcare innovation.
#IITBombay #MEDTRIC #MedicalInnovation #HealthcareInnovation #MedTech #Research #Innovation #PhD #TranslationalResearch
@NoopurRajeMD is simply a world class myeloma doctor and a world class human being. One of the most influential doctors in this space and an inspiration to patients and colleagues alike. Such a well deserved award @IMFmyeloma#mmsm
PRESS RELEASE
International Myeloma Foundation (IMF) and International Myeloma Working Group (IMWG) to Honor 2026 Kyle and Durie Achievement Awardees, Dr. Hermann Einsele and Dr. Noopur Raje
https://t.co/aLu7xfzi8T
This country is woven into every cell of my being. That’s the story of the very existence of my social media profile. I wanted to quit social media in 2024. But then, I made many promises to late Padma Shri Dr. V. Shanta. How could I go back on those promises?
#STEM#CancerCare
@nihardesai89 This thread reminds me of something interesting… did you know that Bone Marrow Adipocytes and Osteoblasts share an common ancestor aka BM-MSCs and when there decrease in Osteoblastogenesis, you see an increase in BM adipogenesis ( and both worsen MM)
I’m heading to the 17th Annual IMWG Summit— one of the most amazing meetings in medicine. It is a working meeting where we gather to discuss and brainstorm all things myeloma. It is one of a kind meeting. It is Team Work at its best!
Team work in myeloma has in part been made possible by strong informal leadership, and respect for each other that we share. The kind where one phone call can solve any problem or misunderstanding. The kind where researchers, patients, pharmaceutical companies, and non-profit organizations have truly come together for a shared goal and vision.
We debate and argue. With 20 new drugs approved in 20 years, the myeloma field has a lot to talk about! But our collective vision is to improve survival and to cure myeloma. We stay focused on that and tune other stuff out. At the start of every IMWG summit we say it doesn’t matter who gets the credit as long as we help myeloma patients. And we mean it.
I have been in the field for over 25 years and I know what we have in myeloma is unique. The Annual IMWG summit organized by @IMFmyeloma epitomizes this team work.
Today's trainees pale in comparison
Dr Harrington, a fellow at WashU, thought ITP was due to a blood factor that caused destruction of platelets
To test hypothesis he took 500 cc 🩸 from a pt with ITP, injected it into himself, ended up hospitalized with severe thrombocytopenia
@Papa_Heme There are tons of great @WashUHematology stories, such as Moore growing spinach with “heavy” (or radio labeled?) iron to image where in his GI system the iron was taken up.